Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 648.55

+0.2%

2:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (3308)	6/15/2021 3:48:58 PM
From: CuttingEdge Bio	Read Replies (1) of 3557

I thought the answer was spot on, and the question is bogus or a red herring. What matters is safety and efficacy. If it was causing 10 times the AEs, then obviously it can't compete. If it was not as efficacious, then obviously can't compete. Neither are true. Why would the difference in dose matter?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next